Cellworks intends to be a fully integrated provider of novel high efficacy and low toxicity personalized pharmaceutical solutions directly to consumers or through alliance with strategic partners. Our business differentiation is an ultra short design time with the lowest development cost and high predictability of success once entering clinical trials.

This is achieved through architecting novel biology driven therapies using our proprietary technology which emulates human disease-physiology conditions computationally. This is further enhanced by creating designs based on existing drugs which have been screened through humans and thereby avoiding chemistry related uncertainties.